Skip to main content
Contact Us
Subscribe
E-Edition
90°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Reata Pharma
(NQ:
RETA
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Sep 25, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
172.36 (11)
Ask (Size)
172.50 (475)
Prev. Close
172.36
Today's Range
N/A - N/A
52wk Range
168.56 - 172.36
Shares Outstanding
36,948,063
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
December 29, 2023
According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.
Via
Benzinga
An Oversold Gold Miner With Strong Fundamentals--Its Relative Strength Index Is Below 20, And Its Piotroski F-Score Is 8
October 05, 2023
Paying Attention To Gold Miners On Zero Hedge on Monday, contributing editor “Quoth The Raven” suggested “paying urgent attention to gold miners”:
Via
Benzinga
Performance
More News
Read More
Reata Pharmaceuticals, Inc. (NASDAQ:RETA) Shareholder Notice: Investigation over Potential Wrongdoing
October 04, 2023
Via
SBWire
Biogen Completes Acquisition of Reata Pharmaceuticals
September 26, 2023
From
Biogen Inc.
Via
GlobeNewswire
Analyst Ratings for Reata Pharmaceuticals
August 15, 2023
Via
Benzinga
Reata Pharmaceuticals Inc. (NASDAQ: RETA) Climbs to New 52-Week High
September 21, 2023
Via
Investor Brand Network
Reata Pharmaceuticals Stockholders Approve Merger Transaction With Biogen Inc.
September 21, 2023
From
Reata Pharmaceuticals, Inc.
Via
Business Wire
Does Biogen's Latest $1.5 Billion-Dollar Move Make It a Buy?
September 09, 2023
Via
The Motley Fool
7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth
September 07, 2023
Via
InvestorPlace
The 7 Most Promising Momentum Stocks to Own Now
August 31, 2023
Via
InvestorPlace
The 3 Most Promising Pharma Stocks to Own Now
August 30, 2023
Via
InvestorPlace
REATA PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Reata Pharmaceuticals, Inc. - RETA
August 28, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Earthstone Energy, Inc. (NYSE - ESTE), Fiesta Restaurant Group, Inc. (Nasdaq - FRGI), Veritiv Corporation (NYSE - VRTV), Reata Pharmaceuticals, Inc. (Nasdaq - RETA)
August 21, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fiesta Restaurant Group, Inc. (Nasdaq - FRGI), Veritiv Corporation (NYSE - VRTV), New Relic, Inc. (NYSE - NEWR), Reata Pharmaceuticals, Inc. (Nasdaq - RETA)
August 17, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
August 14, 2023
Via
Benzinga
With an Acquisition on the Way, Is Biogen Stock a Buy?
August 09, 2023
Via
The Motley Fool
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: EchoStar Corporation (Nasdaq - SATS), Sovos Brands, Inc. (Nasdaq - SOVO), Reata Pharmaceuticals, Inc. (Nasdaq - RETA), Amedisys, Inc. (Nasdaq – AMED)
August 08, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
August 08, 2023
Via
Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fiesta Restaurant Group, Inc. (Nasdaq - FRGI), Veritiv Corporation (NYSE - VRTV), New Relic, Inc. (NYSE - NEWR), Reata Pharmaceuticals, Inc. (Nasdaq - RETA)
August 07, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
REATA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Reata Pharmaceuticals, Inc. - RETA
August 02, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Buy Alert: 3 Biotech Stocks Nearing Super Attractive Entry Points
August 01, 2023
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2023
August 01, 2023
Via
Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: New Relic, Inc. (NYSE - NEWR), Reata Pharmaceuticals, Inc. (Nasdaq - RETA), Talaris Therapeutics, Inc. (Nasdaq - TALS), Inpixon® (Nasdaq - INPX)
August 01, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Biogen's Just Made Its Biggest Acquisition. Here's What You Need to Know.
August 01, 2023
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023
July 31, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.